Introduction to the Founder

Setting up a company with specific focus on developing and launching products for patients suffering from hard to treat, recurring eczema where conventional therapies have failed, was the brainchild of Mo Arif.

With a background in Biochemistry from one of the most prestigious universities in England, Kings’ College London, Mo embarked on a career in the UK pharmaceutical industry where he learnt how big pharmaceutical companies develop, launch, price and market their brands. It was not long before he understood that most companies are not in favour of developing poly-pharmacy products.  Mo explains that this means “products with multiple actions for example, lowering cholesterol, blood pressure and blood glucose with just one tablet, are seldom researched let alone being available to patients”. So, to manage the three conditions, patients would be required to take at least three, sometimes up to six, different tablets to manage their ailments. That means three to six prescriptions to pay for each month!

This, Mo uncovered, was no different in the treatment and management of atopic eczema.